STRIDE-III updates treat-to-target goals in inflammatory bowel disease
STRIDE-III revises inflammatory bowel disease treatment targets, separating actionable, adjunctive, and patient-centred goals for Crohn’s disease and ulcerative colitis.
This section contains the website’s posts.